7,8-Dihydroxyflavone

7,8-DHF is a natural flavonoid which can reach the brain and activate a receptor (TrkB) that promotes neuronal growth. Some animal evidence suggests that 7,8-DHF may have some cognitive and motor benefits and may be nootropic, but no human evidence for these claims exists to date.

Quick Answer

What it is

7,8-DHF is a natural flavonoid which can reach the brain and activate a receptor (TrkB) that promotes neuronal growth. Some animal evidence suggests that 7,8-DHF may have some cognitive and motor benefits and may be nootropic, but no human evidence for these claims exists to date.

Key findings

  • Grade C: Cognitive Function & Memory
  • Grade C: Retinal Ganglion Cell Protection
  • Grade C: Alzheimer's Disease Pathology

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts: 7,8-Dihydroxyflavone

Quick Facts: 7,8-Dihydroxyflavone

  • Best Evidence:Grade C
  • Conditions Studied:7
  • Research Outcomes:15
  • Key Effect:Age-Associated Memory Impairment and Cognitive Decline (AAMCD)
Outcomes by grade:
A0
B0
C4
D11
7 conditions · 15 outcomes

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
C
Cognitive Function & Memory
In multiple rodent models, 7,8-DHF consistently improved spatial memory, long-term memory, and learning. Benefits observed in wildtype mice as well as models of alcohol-induced, sevoflurane-induced, and vascular dementia-related cognitive impairment, with effects mediated through TrkB/BDNF signaling.
moderateImproves
C
Retinal Ganglion Cell Protection
In multiple animal and ex vivo models, 7,8-DHF protected retinal ganglion cells against glaucoma-induced deficits, ischemia-reperfusion injury, chronic intermittent hypoxia, and inherited blindness. Oral administration showed protection via the gut-retina axis and ferroptosis inhibition, with consistent TrkB-mediated neuroprotective effects across models.
moderateImproves
C
Dopaminergic Neuron Survival
In rodent Parkinson's disease models, 7,8-DHF consistently protected nigrostriatal dopaminergic neurons across MPTP-induced, rotenone-induced, and alpha-synuclein transgenic models. Also ameliorated mitochondrial impairment and motor dysfunction, suggesting broad dopaminergic neuroprotective potential via TrkB activation.
moderateImproves
D
Insulin Resistance & Metabolic Markers
In rodent models, 7,8-DHF alleviated endoplasmic reticulum stress in diet-induced metabolic syndrome, attenuated adipocyte-macrophage inflammatory crosstalk and insulin resistance, and showed sex-dependent metabolic effects associated with gut microbiome alterations. Metabolic protection appeared to require an intact gut microbiome.
smallImproves
D
Depressive Symptoms
In rodent models, 7,8-DHF and its O-methylated metabolite reversed depressive symptoms in chronic mild stress paradigms and displayed antidepressant activity via TrkB receptor activation. Effects consistent with BDNF-TrkB signaling role in depression, but limited to animal behavioral assays.
moderateImproves
D
Stroke & Ischemic Brain Injury
In mouse stroke models, 7,8-DHF decreased infarct volumes. In vitro, it protected neurons against oxygen-glucose deprivation-induced apoptosis and activated the TrkB/Akt pathway. Also accelerated recovery in a rat spinal cord lateral hemisection model.
moderateImproves
D
Epilepsy Development
In rodent models, low-dose 7,8-DHF administered after status epilepticus prevented subsequent epilepsy development. However, a separate study found 7,8-DHF potentiated ongoing epileptiform activity in mouse brain slices, indicating potentially opposing acute versus chronic effects that require further investigation.
smallWorsens
D
Neurodevelopmental Disorder Symptoms
In a Fragile X syndrome animal model, early 7,8-DHF administration ameliorated synaptic and behavioral deficits via the BDNF-TrkB pathway. A separate study investigated effects on offspring behavior following maternal immune activation. Both studies suggest potential for neurodevelopmental conditions but evidence is very limited.
smallImproves
D
Hepatoprotection
In a rodent model, 7,8-DHF protected against acetaminophen-induced liver injury through activating PI3K/Akt/NRF2/GPX4-mediated ferroptosis suppression. This represents a single recent preclinical study.
smallImproves
C
Alzheimer's Disease Pathology
In AD mouse models, 7,8-DHF reversed memory deficits, reduced BACE1 and beta-amyloid levels, increased dendritic spine density, and reversed oxidative stress and mitochondrial dysfunction. Consistent neuroprotective effects observed across multiple AD rodent models including scopolamine-induced and ICV-STZ sporadic AD models.
moderateImproves
D
Antioxidant Defense
In cell culture and animal models, 7,8-DHF demonstrated antioxidant effects through HO-1 expression activation, Nrf2 signaling, and caspase inhibition. Protected endothelial cells and neurons against H2O2 and high-glucose-induced oxidative damage. Also reduced lipid peroxidation in a phenylketonuria model.
smallImproves
D
Cardiac Function
In rodent and cell models, 7,8-DHF alleviated cardiac fibrosis via circadian signal restoration, counteracted cardiac hypertrophy through AMPK activation, rescued rotenone-induced cardiomyocyte cytotoxicity, and attenuated cisplatin-induced cardiomyocyte apoptosis via the p53/Nrf2 pathway.
smallImproves
D
Bone Density
In ovariectomy-induced osteoporosis models, 7,8-DHF modulated bone formation and resorption and ameliorated bone loss, including via PI3K/AKT/NRF2 pathway in BMSCs. However, one study found 7,8-DHF impaired fracture healing in mice, suggesting context-dependent effects on bone metabolism.
smallImproves
D
Anxiety
In rodent models, 7,8-DHF alleviated anxiety-like behavior induced by chronic alcohol exposure via TrkB signaling in the amygdala. Also enhanced fear extinction and emotional learning in separate rodent studies, suggesting anxiolytic potential through neurotrophic mechanisms.
smallImproves
D
Motor Neuron Degeneration (ALS)
In SOD1-G93A transgenic mice (ALS model), the 7,8-DHF prodrug R13 preserved motor performance by improving mitochondrial function. This represents a single preclinical study in one ALS mouse model.
smallWorsens

Research Citations (48)

7,8-Dihydroxyflavone protects acetaminophen induced liver injury through activating PI3K/Akt/NRF2/GPX4 mediated ferroptosis suppression
(2026)
PMID: 41173313
Oral 7,8-Dihydroxyflavone Protects Retinal Ganglion Cells by Modulating the Gut-Retina Axis and Inhibiting Ferroptosis via the Indoleacrylic Acid-AhR-ALDH1A3-FSP1 Pathway
(2025)
PMID: 40365730
7,8-Dihydroxyflavone attenuates cisplatin-induced cardiomyocyte apoptosis and mitochondrial dysfunction via the p53/Nrf2 pathway
(2025)
PMID: 40992637
7,8-Dihydroxyflavone ameliorates cognitive impairment induced by repeated neonatal sevoflurane exposures in mice through increasing tau O-GlcNAcylation
(2024)
PMID: 37984484
7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia
(2024)
PMID: 38300457
7,8-DHF inhibits BMSC oxidative stress via the TRKB/PI3K/AKT/NRF2 pathway to improve symptoms of postmenopausal osteoporosis
(2024)
PMID: 39155025
7,8-dihydroxyflavone displayed antioxidant effect through activating HO-1 expression and inhibiting caspase-3/PARP activation in RAW264.7 cells
(2024)
PMID: 38053484
7,8-dihydroxyflavone reduces lipid peroxidation, proinflammatory cytokines, and mediators in chemically induced phenylketonuria model
(2024)
PMID: 39392024
Investigating 7,8-Dihydroxyflavone to combat maternal immune activation effects on offspring gene expression and behaviour
(2024)
PMID: 38950841
7,8-dihydroxyflavone enhances long-term spatial memory and alters brain volume in wildtype mice
(2023)
PMID: 37008453

Related Supplements

Spikenard

4 shared conditions · 8 outcomes

Spikenard (Jatamansi) is an Ayurvedic herb traditionally used for calming, cognitive enhancement, and neuroprotection. Similar traditional uses to Bacopa but with less research. Contains sesquiterpenes and volatile oils. NO GRADED OUTCOMES - human research is very limited. Preclinical studies show neuroprotective potential. Traditionally used for epilepsy, anxiety, and memory. The plant is endangered due to overharvesting; sustainable sourcing is a concern.

Salidrosides

4 shared conditions · 11 outcomes

Salidroside is a glucoside compound and one of the main bioactive constituents of Rhodiola rosea. Often standardized in Rhodiola extracts (typically 1-3%). Has neuroprotective and adaptogenic properties. Research shows anti-fatigue, anti-stress, and potential anti-depressant effects. Mechanism involves HPA axis modulation, AMPK activation, and antioxidant effects. Most clinical evidence is for the whole Rhodiola rosea extract rather than isolated salidroside. May be more effective as part of whole plant extract than in isolation.

Myricetin

4 shared conditions · 8 outcomes

Myricetin is a flavonoid found in berries, vegetables, and wine, structurally related to quercetin and kaempferol. Among flavonoids, myricetin has been particularly associated with bone health and anti-osteoporotic effects in preclinical research. Also has antioxidant and potential anti-diabetic properties. NO GRADED OUTCOMES - human research is limited. Found in foods like berries, onions, and red wine. Not widely available as an isolated supplement. Low bioavailability may limit therapeutic use.

Muira puama

4 shared conditions · 6 outcomes

Muira puama is a Brazilian herb traditionally used as an aphrodisiac and nerve tonic. The nickname 'Potency Wood' reflects its traditional sexual health use, but human evidence for sexual benefits is weak. Interestingly, preliminary research suggests it may be effective as a COGNITIVE ENHANCER rather than an aphrodisiac. Contains lupeol and other triterpenoids. NO GRADED OUTCOMES - lacks quality human trials for either sexual or cognitive claims. The cognitive enhancement angle warrants more research.

Cyanidin

4 shared conditions · 10 outcomes

Cyanidin is a type of anthocyanin pigment found in dark berries, purple vegetables, and black rice. Cyanidin-3-glucoside (C3G) is the most studied form. Shows promise for blood glucose regulation, anti-inflammatory effects, and metabolic health. Notable for potentially improving glucose uptake without impairing muscle protein synthesis (unlike some AMPK activators). However, bioavailability is a major concern - most cyanidin is rapidly metabolized. Human evidence is limited despite promising in vitro data.

Convolvulus pluricaulis

4 shared conditions · 7 outcomes

Convolvulus pluricaulis is a traditional Ayurvedic herb classified as a 'medhya rasayana' (brain tonic). Known as Shankhpushpi, though this name refers to multiple herbs depending on region. Used traditionally for memory, anxiety, and as a general nootropic. Animal studies show anxiolytic, memory-enhancing, and anticonvulsant effects. Contains flavonoids, glycosides, and alkaloids. Human clinical evidence is extremely limited - primarily traditional use and animal research.

Red Berry Powder

3 shared conditions · 3 outcomes

Red Berry Powder is a concentrated blend of powdered red berries (raspberries, strawberries, goji berries, cranberries, etc.). Contains anthocyanins, polyphenols, and fiber. Marketed for antioxidant, cardiovascular, and general health benefits. Effects depend entirely on the specific berries included and their concentrations. No standardized formulation exists. Individual berries (blueberries, cranberries) have more research than mixed blends. Essentially a convenient way to consume berry polyphenols if whole berries aren't available.

Palmatine

3 shared conditions · 9 outcomes

Palmatine is a protoberberine alkaloid found alongside berberine in plants like Coptis, Phellodendron, and Berberis. Shares many mechanisms with berberine (AMPK, metabolic effects) but less potent. Some unique sedative/anxiolytic properties via GABA-A and D2 receptor modulation. Used in Traditional Chinese Medicine. Limited human studies compared to berberine. May contribute to effects of berberine-containing extracts but rarely supplemented alone.